FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $302,000 | +172.1% | 15,151 | -5.9% | 0.00% | – |
| Q2 2022 | $111,000 | -35.1% | 16,093 | -12.7% | 0.00% | – |
| Q1 2022 | $171,000 | -97.6% | 18,425 | -96.3% | 0.00% | -100.0% |
| Q4 2021 | $7,104,000 | -39.1% | 499,623 | -0.7% | 0.00% | -50.0% |
| Q3 2021 | $11,670,000 | -6.2% | 503,241 | +0.6% | 0.01% | 0.0% |
| Q2 2021 | $12,447,000 | -11.0% | 500,091 | +0.2% | 0.01% | -25.0% |
| Q1 2021 | $13,985,000 | +1818.4% | 499,095 | +2288.6% | 0.01% | – |
| Q4 2020 | $729,000 | +69.5% | 20,895 | +142.5% | 0.00% | – |
| Q3 2020 | $430,000 | – | 8,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |